Cargando…

Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population‐based study

BACKGROUND: The condition of tumor recurrence and overall death can be worried in the progress of nonmetastatic malignant melanoma (NMMM). Our goal was to construct and validate a prognostic nomogram from a large population database, which is vital for physicians to predict the 3‐ and 5‐year overall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Yu, Peng, Shanshan, Hu, Youhong, Zhang, Jie, Cao, Xianwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666721/ https://www.ncbi.nlm.nih.gov/pubmed/32941704 http://dx.doi.org/10.1002/cam4.3318

Ejemplares similares

Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer
por: Hong, Tingting, et al.
Publicado: (2020)

Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma
por: Shao, Yanxiang, et al.
Publicado: (2019)

Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database
por: Li, Xinrong, et al.
Publicado: (2020)

Time‐dependent and nonlinear effects of prognostic factors in nonmetastatic colorectal cancer
por: Chi, Sheng‐Qiang, et al.
Publicado: (2017)

Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
por: Bao, Shengnan, et al.
Publicado: (2021)

Development and validation of a prognostic nomogram for ambulatory patients with advanced cancer
por: Paiva, Carlos Eduardo, et al.
Publicado: (2018)

Construction and validation of a prognostic nomogram for anal squamous cell carcinoma
por: Yang, Ningning, et al.
Publicado: (2021)

Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis
por: Sadetsky, Natalia, et al.
Publicado: (2020)

Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population‐based study
por: van der Geest, Lydia G. M., et al.
Publicado: (2018)

Expression of immune checkpoint receptors Indoleamine 2,3‐dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma
por: Stålhammar, Gustav, et al.
Publicado: (2019)

The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer
por: Gruhl, Joshua D., et al.
Publicado: (2020)

Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma
por: Kobayashi, Kenya, et al.
Publicado: (2016)

Development and validation of prognostic nomogram for patients with metastatic gastric adenocarcinoma based on the SEER database
por: Liu, Xianming, et al.
Publicado: (2023)

Competitive Risk Model Nomogram to Predict Prognosis in Patients Aged Over 65 Years with nonmetastatic Cervical Cancer: A SEER Population-Based Study
por: Jiao, Shengyuan, et al.
Publicado: (2023)

Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis
por: Jani, Krupa S., et al.
Publicado: (2021)

Development and validation of prognostic nomogram in ependymoma: A retrospective analysis of the SEER database
por: Jia, Zetian, et al.
Publicado: (2021)

Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer
por: Kanematsu, Masako, et al.
Publicado: (2015)

Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment
por: Srinivas, Sandy, et al.
Publicado: (2020)

Factors associated with cognitive impairment during the first year of treatment for nonmetastatic breast cancer
por: Rodriguez, Nicole, et al.
Publicado: (2021)

Development and validation of a prognostic nomogram for predicting cancer‐specific survival after radical cystectomy in patients with bladder cancer:A population‐based study
por: Yang, Zhiqiang, et al.
Publicado: (2020)

Prognostic significance of laterality in renal cell carcinoma: A population‐based study from the surveillance, epidemiology, and end results (SEER) database
por: Guo, Shengjie, et al.
Publicado: (2019)

Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis
por: Liu, Hong, et al.
Publicado: (2019)

Construction and validation of a novel prognostic nomogram for patients with metastatic renal cell carcinoma: a SEER-based study
por: Lu, Zhaoxiang, et al.
Publicado: (2022)

Prognostic factors and survival prediction in hepatocellular carcinoma: development and validation of a novel nomogram based on the SEER database
por: Huang, Shanshan, et al.
Publicado: (2023)

Development and validation of tumor‐size‐stratified prognostic nomograms for patients with uterine sarcoma: A SEER database analysis
por: Cao, Shiyu, et al.
Publicado: (2022)

Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma
por: Cui, Jie, et al.
Publicado: (2020)

Development and Validation of Prognostic Nomograms for Periampullary Neuroendocrine Neoplasms: A SEER Database Analysis
por: Chen, Jinghua, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for neuroendocrine prostate cancer, based on the SEER database
por: Chen, Siming, et al.
Publicado: (2023)

Impact of serious mental illness on the treatment and mortality of older patients with locoregional high‐grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER‐Medicare patients diagnosed between 2006 and 2013
por: Fried, Dennis A., et al.
Publicado: (2019)

Clinicopathological characteristics and survival outcomes in pleomorphic lobular breast carcinoma of the breast: a SEER population‐based study
por: Yang, Li‐Peng, et al.
Publicado: (2017)

Clinicopathological characteristics and survival outcomes in Paget disease: a SEER population‐based study
por: Zhao, Yang, et al.
Publicado: (2018)

Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer
por: Suzuki, Hiroyoshi, et al.
Publicado: (2019)

Prospective validation of the prognostic 31‐gene expression profiling test in primary cutaneous melanoma
por: Keller, Jennifer, et al.
Publicado: (2019)

Prognostic nomogram based on immune scores for breast cancer patients
por: Wang, Ju, et al.
Publicado: (2019)

Prognostic factors in breast phyllodes tumors: a nomogram based on a retrospective cohort study of 404 patients
por: Zhou, Zhi‐Rui, et al.
Publicado: (2018)

Development and Validation of Prognostic Survival Nomograms for Patients with Anal Canal Cancer: A SEER-Based Study
por: Tang, Jie, et al.
Publicado: (2021)

Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis
por: Jin, Di, et al.
Publicado: (2020)

Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study
por: Huang, Qin, et al.
Publicado: (2019)

Clinical characteristics and disease-specific prognostic nomogram for primary gliosarcoma: a SEER population-based analysis
por: Feng, Song-Shan, et al.
Publicado: (2019)

Establishment and validation of a prognostic nomogram for patients with renal cell carcinoma based on SEER and TCGA database
por: Wang, Changming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pc9fbujt27gp2m31ne6kdhokcm